Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
CORLANOR (IVABRADINE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
CORLANOR
NDA
Get alerts
IVABRADINE | N209964 | AMGEN INC
1 strength
4 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
4 unique patents, 1 exclusivity by expiration date
Expired (3)
Expiring < 1yr (1)
Today
PED (+6 mo)
Exclusivity
2027
Today
7361649
Feb. 22, 2026
7361650
Feb. 22, 2026
7867996
Dec. 12, 2026
7879842
Feb. 22, 2026
ODE-234
Oct. 22, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 5MG/5ML (1MG/ML)
RLD
4 patents
2 exclusivities
▴
SOLUTION;ORAL | Approved: Apr 22, 2019
Patents (4)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7361649
Feb 22, 2026
—
Yes
Yes
U-1694
A METHOD FOR TREATING HEART FAILURE IN A HUMAN USING A CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE
—
7361650
Feb 22, 2026
—
Yes
Yes
U-1694
A METHOD FOR TREATING HEART FAILURE IN A HUMAN USING A CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE
—
7867996
Dec 12, 2026
—
Yes
Yes
U-1694
A METHOD FOR TREATING HEART FAILURE IN A HUMAN USING A CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE
—
7879842
Feb 22, 2026
—
Yes
Yes
U-1694
A METHOD FOR TREATING HEART FAILURE IN A HUMAN USING A CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE
—
Exclusivities (2)
Code
Date
Status
ODE-234
Apr 22, 2026
Expired
PED
Oct 22, 2026
< 1 year